Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Combination therapy with a nucleos(t)ide analogue and interferon for chronic hepatitis B: simultaneous or sequential.

Enomoto M, Tamori A, Nishiguchi S, Kawada N.

J Gastroenterol. 2013 Sep;48(9):999-1005. doi: 10.1007/s00535-012-0742-5. Epub 2013 Jan 22. Review.

PMID:
23338486
2.

A Better Antiviral Efficacy Found in Nucleos(t)ide Analog (NA) Combinations with Interferon Therapy than NA Monotherapy for HBeAg Positive Chronic Hepatitis B: A Meta-Analysis.

Wei W, Wu Q, Zhou J, Kong Y, You H.

Int J Environ Res Public Health. 2015 Aug 21;12(8):10039-55. doi: 10.3390/ijerph120810039.

3.

[Comparison of peg-interferon monotherapy to peg-interferon and nucleoside analogue combination therapy for hepatitis B: a meta-analysis of randomized controlled trials].

Li MY, Yuan XL, Zhang DZ.

Zhonghua Gan Zang Bing Za Zhi. 2012 Jun;20(6):442-7. doi: 10.3760/cma.j.issn.1007-3418.2012.06.013. Chinese.

PMID:
23044202
4.

Customizing the management of chronic hepatitis B virus infection.

Gish RG, Perrillo RP, Jacobson IM.

Semin Liver Dis. 2007 Aug;27 Suppl 1:9-17. Review.

PMID:
17701845
5.

Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis B.

Wong GL, Wong VW, Chan HL.

J Viral Hepat. 2014 Dec;21(12):825-34. doi: 10.1111/jvh.12341. Review.

PMID:
25402543
6.
7.

Systematic review: combination therapies for treatment-naïve chronic hepatitis B.

Kumar M, Sarin SK.

Aliment Pharmacol Ther. 2008 Jun;27(12):1187-209. doi: 10.1111/j.1365-2036.2008.03695.x. Epub 2008 Mar 28. Review.

8.

The suppressive effect of nucleos(t)ide analogue treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients.

Hiramatsu N, Yamada R, Takehara T.

J Gastroenterol Hepatol. 2016 Mar;31(3):546-52. doi: 10.1111/jgh.13229. Review.

PMID:
26574149
9.

Latest developments in the treatment of hepatitis B.

Dandri M, Petersen J.

Minerva Gastroenterol Dietol. 2016 Mar;62(1):88-102. Epub 2015 Oct 8. Review.

PMID:
26448309
10.

Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B.

Reijnders JG, Perquin MJ, Zhang N, Hansen BE, Janssen HL.

Gastroenterology. 2010 Aug;139(2):491-8. doi: 10.1053/j.gastro.2010.03.059. Epub 2010 Apr 8.

PMID:
20381492
11.

Impact of nucleos(t)ide analogue combination therapy on the estimated glomerular filtration rate in patients with chronic hepatitis B.

Qi X, Wang J, Chen L, Huang Y, Qin Y, Mao R, Zhang J.

Medicine (Baltimore). 2015 Apr;94(15):e646. doi: 10.1097/MD.0000000000000646.

12.

Optimal therapy for chronic hepatitis B: hepatitis B virus combination therapy?

Petersen J, Dandri M.

Liver Int. 2015 Jan;35 Suppl 1:114-20. doi: 10.1111/liv.12720. Review.

PMID:
25529096
13.

Review article: the potential of interferon and nucleos(t)ide analogue combination therapy in chronic hepatitis B infection.

Viganò M, Invernizzi F, Grossi G, Lampertico P.

Aliment Pharmacol Ther. 2016 Oct;44(7):653-61. doi: 10.1111/apt.13751. Epub 2016 Aug 16. Review.

PMID:
27528410
14.

HBeAg-positive chronic hepatitis B: why do i treat my patients with Nucleos(t)ide analogs?

Buti M.

Liver Int. 2014 Feb;34 Suppl 1:108-11. doi: 10.1111/liv.12392. Review.

PMID:
24373086
15.

Treatment of chronic hepatitis B: case selection and duration of therapy.

Leung N.

J Gastroenterol Hepatol. 2002 Apr;17(4):409-14. Review.

PMID:
11982721
16.

When to stop nucleos(t)ide analogues treatment for chronic hepatitis B? Durability of antiviral response.

Kang W, Park JY.

World J Gastroenterol. 2014 Jun 21;20(23):7207-12. doi: 10.3748/wjg.v20.i23.7207. Review.

17.

[Treatment of chronic hepatitis B].

Asselah T, Lada O, Boyer N, Martinot M, Marcellin P.

Gastroenterol Clin Biol. 2008 Aug-Sep;32(8-9):749-68. doi: 10.1016/j.gcb.2008.07.001. Epub 2008 Sep 4. Review. French.

18.

Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients.

Jung SK, Kim KA, Ha SY, Lee HK, Kim YD, Lee BH, Paik WH, Kim JW, Bae WK, Kim NH, Lee JS, Jwa YJ.

Clin Mol Hepatol. 2015 Mar;21(1):41-8. doi: 10.3350/cmh.2015.21.1.41. Epub 2015 Mar 25.

19.

Management of viral hepatitis B.

Pramoolsinsup C.

J Gastroenterol Hepatol. 2002 Feb;17 Suppl:S125-45. Review.

PMID:
12000599
20.

Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.

Buster EH, Schalm SW, Janssen HL.

Best Pract Res Clin Gastroenterol. 2008;22(6):1093-108. doi: 10.1016/j.bpg.2008.11.007. Review.

PMID:
19187869

Supplemental Content

Support Center